Cover Image

USE OF COMBINED THERAPY WITH LOCALIZED ADMINISTRATION OF INFLIXIMAB IN CHILDREN WITH CONTINUOUSLY RECURRENT PERIANAL CROHN'S DISEASE

Show other versions (1)

(Pediatric Pharmacology. - 2010; 7(4):117-121)

Saved in:

Bibliographic Details
Main Author:	O.V. Shcherbakova (Author)
Format:	Book
Published:	Union of pediatricians of Russia, 2010-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

USE OF COMBINED THERAPY WITH LOCALIZED ADMINISTRATION OF INFLIXIMAB IN CHILDREN WITH CONTINUOUSLY RECURRENT PERIANAL CROHN'S DISEASE
by: O.V. Shcherbakova
Published: (2010)

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE
by: E.N. Fedulova, et al.
Published: (2009)

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE
by: E.N. Fedulova, et al.
Published: (2009)

Metastatic Crohn's disease despite infliximab therapy
by: Sara Campos, et al.
Published: (2017)

Early intestinal obstruction after infliximab therapy in Crohn's disease
by: Mitsuro Chiba, et al.
Published: (2019)

Loss of Response to Long-Term Infliximab Therapy in Children with Crohn's Disease
by: George Alex, et al.
Published: (2013)

Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection - Reply
by: M. Galeazzi
Published: (2003)

Profile of infliximab in the treatment of pediatric Crohn’s disease
by: Kierus J, et al.
Published: (2015)

Treatment of perianal fistulas in Crohn's disease - review of literature and current recommendations
by: Dominik Szawica, et al.
Published: (2023)

Gummatous cutaneous tuberculosis associated with the use of infliximab for Crohn's disease,
by: Lucas Campos Garcia, et al.
Published: (2021)

The impact of medication belief on adherence to infliximab in patients with Crohn's disease
by: Shuyan Li, et al.
Published: (2023)

Cortical Vein Thrombosis after Infliximab Treatment for Crohn's Disease
by: Saeed Razmeh, et al.
Published: (2021)

Severe Vulvar and Perianal Crohn's Disease: A Case Report and Review of the Literature
by: Guillaume Le Cosquer, et al.
Published: (2022)

Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile
by: Luz María Medrano, et al.
Published: (2015)

The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn's Disease with Infliximab
by: Marla C. Dubinsky, et al.
Published: (2023)

Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn's Disease
by: Qianqian Li, et al.
Published: (2021)

Infliximab-induced intertriginous psoriasis in patient with Crohn's desease
by: Federica Mola, et al.
Published: (2011)

Clinical Example of Efficiency of the Multidisciplinary Approach to the Management of a Patient with Crohn's Disease Complicated by Perianal Lesions
by: Tatyana V. Gabrusskaya, et al.
Published: (2016)

A novel role of the splenic volume in Crohn's disease: evaluating the efficacy of infliximab
by: Xuan Shi, et al.
Published: (2023)

Development of Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab Therapy: A Case Report With Literature Review
by: Jae Hoon Jung, et al.
Published: (2022)

Vaginal delivery in women with perianal Crohn's disease: why not?AJOG Global Reports at a Glance
by: Irene J. Schaafsma, MSc, et al.
Published: (2024)

Clinical characteristics and MRI-based phenotypes of perianal abscess formation in children with fistulizing Crohn's Disease
by: Azadeh Tabari, et al.
Published: (2022)

Tracing the historical foundations of infliximab in Crohn's disease treatment: a cited reference analysis
by: Andy Wai Kan Yeung
Published: (2024)

Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease
by: Kouzhu Zhu, et al.
Published: (2024)

Erythema dyschromicum perstans (ashy dermatosis) during the treatment with infliximab in a child with Crohn disease
by: Michał Sobjanek, et al.
Published: (2014)

Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn's Disease
by: Beatriz Orts, et al.
Published: (2022)

The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China
by: Wenhui Hu, et al.
Published: (2021)

Case Report: Infusion-Related Reactions to Intravenous Infliximab and Subcutaneous Ustekinumab in Pediatric Crohn's Disease
by: Toshihiko Kakiuchi, et al.
Published: (2021)

Recurrent perianal wart therapy with 90% trichloroacetate (TCA) solution in AIDS patients
by: Sri Linuwih SW Menaldi, et al.
Published: (2019)

FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization
by: Ye C, et al.
Published: (2024)

Clinical efficacy of combined therapy for perianal eczema caused by anal diseases in 160 cases
by: Zhi-Chao LIU, et al.
Published: (2007)

ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN'S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
by: Ivaylo Vazharov, et al.
Published: (2016)

Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn's Disease Patients
by: Yueying Chen, et al.
Published: (2021)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
by: Ashley Fonseca, et al.
Published: (2021)

A Case of a Two-Month-Old Boy Diagnosed with Infantile Crohn's Disease Based on an Atypical Perianal Lesion
by: Kengo Nakaya, et al.
Published: (2020)

A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn's disease
by: Shin Kashima, et al.
Published: (2022)

Successful treatment of infliximab-induced psoriasiform skin lesions despite biologic therapy intensification in a paediatric patient with Crohn's disease and primary sclerosing cholangitis
by: Agata Wasilewska, et al.
Published: (2021)

Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn's disease
by: Kouzhu Zhu, et al.
Published: (2023)

Infliximab as rescue therapy in refractory Kawasaki disease
by: Moisés Rodríguez-González, et al.
Published: (2014)

Biological therapies in Crohn's disease
by: Patryk Kaczor, et al.
Published: (2018)